Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ZAVEGEPANT vs ZIMBERELIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ZAVEGEPANT vs ZIMBERELIMAB: Safety Overview

Metric ZAVEGEPANT ZIMBERELIMAB
Total FAERS Reports 645 193
Deaths Reported 0 62
Death Rate N/A 32.1%
Hospitalizations 6 181
Average Patient Age 46.1 yrs 63.6 yrs
% Female Patients 89.8% 48.3%
FDA Approval Date Mar 9, 2023 N/A
Manufacturer Pfizer Laboratories Div Pfizer Inc N/A
Route NASAL N/A
Marketing Status Prescription N/A